Post hoc responder analyses of subjective and objective outcomes using pooled data from 3 randomised Phase III trials of mirabegron in patients with overactive bladder

Castro Díaz D1, Chapple C2, Hakimi Z3, Blauwet M B4, Delgado-Herrera L4, Fitzsimmons W4, Lau W4, Mujais S4

Abstract Category

Quality of Life (QoL)

Abstract 294
Pharmacology
Scientific Podium Poster Session 32
Friday 30th August 2013
16:45 - 16:50
116
Clinical Trial Incontinence Outcomes Research Methods Overactive Bladder Quality of Life (QoL)
1. University Hospital Canary Islands, 2. Royal Hallamshire Hospital, Department of Urology, Sheffield, UK, 3. Astellas Pharma Europe Ltd, 4. Astellas Pharma Global Development, Inc
Presenter
D

David Castro Díaz
University Hospital Canary Islands
Links

Abstract

20/11/2024 06:37:07